- Coordinator
- Chalmers Tekniska Hogskola Aktiebolag, Sweden
- Runs
- 1 September 2026 to 31 August 2031
- Status
- Running
- EU funding
- €2.0m
- Total cost
- €2.0m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101230596
What the project is doing
In the project's own words, from its summary on CORDIS.
Minute changes in proteins—such as a single amino acid substitution—can profoundly impact cellular function. A computational model capable of systematically mapping the relationship between protein sequences, their dynamics, and their interactions with other biomolecules would revolutionize biology and enable rational, physics-informed bioengineering applications. SPETITO outlines the methodological foundations for such a framework.
Recent advances in deep generative AI (GenAI) have enabled surrogate methods for efficient molecular dynamics (MD) simulations, tackling the challenge of sampling rare events and conformational transitions. The PI co-developed groundbreaking methods—Boltzmann Generators (BG) and Implicit Transfer Operators (ITO)— that enable the study of conformational changes, protein folding, and prediction of experiments five orders of magnitude faster than MD.However, these methods cannot generalize across molecular systems nor scale to larger molecules, severelylimiting their utility.
To address this, we propose developing and disseminating transformative technologiesthrough widely accessible software:• A transferable ITO (TransITO) model that captures universal protein physics, enabling rapid samplingwith microsecond-time-steps for any protein system without requiring system-specific training data.• A ‘protein sequence gradient’-based optimization framework, enabling efficient exploration and optimization of protein sequence space for targeted functional outcomes.• An automated protocol for protein design that integrates multiple thermodynamic constraints, facilitating the rational engineering of proteins with desired properties.
Beyond turbo-charged atomic-resolution insights into biophysics, TransITO will enable rational, physics-informed protein engineering. With experimental collaborators, we will apply TransITO to vaccine development, to accelerate therapeutic design for infectious diseases.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Chalmers Tekniska Hogskola Aktiebolag | Goteborg | Sweden | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI